Sertindole: A review of clinical efficacy

International Clinical Psychopharmacology

Volumn 13, Issue SUPPL. 3, 1998, Pages

  Kane, John M ^a  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

Efficacy; Haloperidol; Negative symptoms; Sertindole

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; SERTINDOLE;

ADULT; AKATHISIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EJACULATION; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HUMAN TISSUE; NEUROTOXICITY; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; REVIEW; SCHIZOPHRENIA;

EID: 0031800668     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199803003-00010     Document Type: Review

References (8)

1. American Psychiatric Association (1987). DSM-III-R: Diagnostic and statistical manual of mental disorders. 3rd ed. rev. Washington (DC): American Psychiatric Association.
2. Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL (1993). Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl J Med 329:162-167.
3. Casey DE (1989). Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology 53 (suppl 99):S47-S53.
4. Hale A, Van der Burght M, Wehnert A, Sloth-Neilsen M (1996). A European dose-range study comparing the efficacy, tolerability and safety of four doses of sertindole and one dose of haloperidol in schizophrenic patients [abstract]. In: 35th American College of Neuropsychopharmacology Annual Meeting, San Juan, Puerto Rico, December 1996. Nashville (TN): American College of Neuropsychopharmacology. p. 252.
5. Kane JM, Cooper TB, Sacher EJ, Halpern SS, Bailine S (1981). Clozapine: plasma levels and prolactin response. Psychopharmacology 73:184-187.
6. Kane JM, Honigfeld G, Singer J, Meltzer H (1988). Clozapine for the treatment-resistant schizophrenic: a double-blind comparison versus chlorpromazine/benztropine. Arch Gen Psychiatry 45:789-796.
7. Kane JM, Woerner M, Safferman A, Pollack S, Lieberman J (1993). Does clozapine cause tardive dyskinesia? J Clin Psychiatry 54:327-330.
8. Zimbroff DL, Kane JM, Tamminga CA, Daniel DG, Mack RJ, Wozniak PJ, et al. (1997). Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Am J Psychiatry 154:782-791.